Behind the case: How TissueGen beat Boston Scientific
Law firm Susman Godfrey’s John Lahad explains how his firm and its co-counsel snagged a $42 million verdict for the University of Texas System and TissueGen
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: